We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

36 hedge funds and large institutions have $79.4M invested in Assembly Biosciences in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $61.9M → $79.4M (+$17.5M)

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less funds holding

Funds holding: 43 → 36 (-7)

88% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 8

Holders
36
Holders Change
-7
Holders Change %
-16.28%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
12
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACP
Acuta Capital Partners
California
+$571K
2
TDC
Thompson Davis & Co
Virginia
+$91.9K
3
ACA
Avoro Capital Advisors
New York
+$45.9K
4
BFA
BlackRock Fund Advisors
California
+$42.6K
5
TRCT
Tower Research Capital (TRC)
New York
+$36.3K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$401K
2
PP
Paloma Partners
Connecticut
-$314K
3
CS
Credit Suisse
Switzerland
-$220K
4
DCM
Dialectic Capital Management
Connecticut
-$219K
5
PA
Perceptive Advisors
New York
-$112K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$21.2M – – –
Jennison Associates
2
Jennison Associates
New York
$14.6M -$48.3K -625 -0.4%
O
3
OrbiMed
New York
$10.1M – – –
PA
4
Perceptive Advisors
New York
$5.61M -$112K -1,444 -2%
QF
5
QVT Financial
New York
$5.06M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.13M – – –
RSCM
7
Rock Springs Capital Management
Maryland
$2.81M – – –
PI
8
Putnam Investments
Massachusetts
$2.67M – – –
Millennium Management
9
Millennium Management
New York
$2.62M -$401K -5,186 -15%
ACP
10
Acuta Capital Partners
California
$2.27M +$571K +7,397 +39%
ACA
11
Avoro Capital Advisors
New York
$1.93M +$45.9K +594 +3%
BIT
12
BlackRock Institutional Trust
California
$1.93M +$13.6K +176 +0.8%
BBA
13
Baker Bros. Advisors
New York
$1.8M – – –
SM
14
Sabby Management
Florida
$542K -$97.6K -1,263 -17%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$521K +$309 +4 +0.1%
BFA
16
BlackRock Fund Advisors
California
$327K +$42.6K +552 +17%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$299K – – –
William Blair & Company
18
William Blair & Company
Illinois
$295K – – –
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$294K -$43.9K -568 -14%
Northern Trust
20
Northern Trust
Illinois
$292K +$5.79K +75 +2%
Goldman Sachs
21
Goldman Sachs
New York
$165K -$9.81K -127 -6%
BRWA
22
B. Riley Wealth Advisors
Florida
$143K -$19.1K -247 -13%
CS
23
Credit Suisse
Switzerland
$109K -$220K -2,844 -69%
TDC
24
Thompson Davis & Co
Virginia
$107K +$91.9K +1,190 +2,833%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$106K -$63.1K -817 -40%
1
2

ASMB Hedge Fund Activity: Q3 2016 in Review

36 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2016, worth a combined $79.4M — up 28% from $61.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ASMB and 1 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 12 added.

The largest buyer was Acuta Capital Partners, adding an estimated $571K. The largest seller was Millennium Management, cutting an estimated $401K.

  • 36 institutional investors held Assembly Biosciences (ASMB) as of Q3 2016, down from 43 in Q2 2016.
  • Funds reported $79.4M of Assembly Biosciences stock for Q3 2016, up 28% quarter-over-quarter.
  • 1 fund opened new Assembly Biosciences positions in Q3 2016 and 8 closed out, a net change of -7 holders.
  • The largest Assembly Biosciences buyer in Q3 2016 was Acuta Capital Partners, an estimated $571K added.
  • The largest Assembly Biosciences seller in Q3 2016 was Millennium Management, an estimated $401K sold.

Based on aggregated 13F filings for Q3 2016.